We are currently searching for volunteers near Oxford to contribute to this important research which could have lasting implications for improving prenatal care and early anomaly detection.
Applications are now open for graduate study at the University of Oxford. There are more than 25 research and 30 taught courses in different subject areas across the Medical Sciences Division. If you are considering joining the 2,500+ students who are already part of our thriving research culture, please watch this video and contact us for more information.
A recent research study published in BJOG: An International Journal of Obstetrics & Gynaecology reveals that a significant majority of women with chronic pelvic pain (CPP) experience recurrent symptom flares, leading to considerable impact on their daily lives. The study, conducted by a multidisciplinary team led by Lydia Coxon and her colleagues, represents a critical advancement in understanding the triggers and variability of these debilitating episodes.
AI is revolutionising healthcare globally, with technologies like ChatGPT now at the forefront. ChatGPT can generate text that sounds remarkably human\u2014so much so that humans cannot discern between text written by ChatGPT and that produced by humans. People worldwide use it for tasks ranging from managing finances to writing poetry, often with impressive results. Recently, however, its use in providing medical advice has raised significant concerns.
Professor Ahmed Ahmed and Dr Nancy Zaarour have received funding from Cancer Research UK to undertake preclinical testing of a preventative vaccine for ovarian cancer. The vaccine would teach the immune system to recognise and attack the earliest stages of ovarian cancer. The team will receive up to \u00a3600,000 for the study over the next three years to support lab research into the vaccine.
The Nuffield Department of Women's & Reproductive Health at the University of Oxford (NDWRH) is proud to announce that on Monday 23 September 2024, the department was awarded the prestigious Athena Swan Gold Award. This achievement follows a rigorous and substantial application process, reaffirming the department\u2019s commitment to gender equality and the promotion of diversity within science and higher education.
This week, we celebrated Postdoc Appreciation Week by honouring the contributions of our talented postdocs at the University of Oxford. Their work and commitment makes a huge difference to our research projects and raising the profile of women's health issues.
The FemTech Forward Conference 2024 marked the first conference in this field in Oxford. Led by Christiane Hagel, the event gathered over 80 participants from diverse disciplines to explore advancements in women's health technology. Amongst other speakers were Professor Christian Becker and Dr Tatjana Gibbons.
The inner lining of the uterus, the endometrium, has been mapped during multiple phases of the menstrual cycle, starting to shed new light on the cells and processes involved and their potential role in conditions such as endometriosis.
The University of Oxford has joined forces with Aarhus University and the University of Copenhagen to create a new Pioneer Centre that will become a significant international partner for data-driven medical research. The Pioneer Centre is anchored at Aarhus University with hub sites at each of the three universities and with a total grant of DKK 250 million.
It is with deep sadness that we share the news of the passing of our esteemed colleague, Professor Christopher Redman.\r\n\r\nChris was a global pioneer in maternity care. A physician by training, he was among the first to recognise the critical importance of both pre-existing medical conditions and diseases unique to pregnancy, particularly pre-eclampsia, in ensuring the safety of mother and child. His work in this area made him a world leader.
We are delighted to celebrate the remarkable achievements of Intelligent Ultrasound, a pioneering company that began as a spin-out from the University of Oxford in 2012. Co-founded by Prof. Alison Noble and Prof. Aris Papageorghiou, Intelligent Ultrasound has made significant strides in transforming ultrasound technology through cutting-edge artificial intelligence (AI).
Huge congratulations to MSc Research student, Charlie Elwes who won gold this week in the men\u2019s eights.\r\n\r\nAnd a big shoutout to Heidi Long, whHeidi Long (due to be starting an MRes with Prof. Williams) who won Bronze in the women\u2019s eights.
Today, our article in Nature Reviews Endocrinology highlighted the urgent necessity for expanded research into the impact of heat exposure on the endocrine system.
Official Press release: A \u00a39.12 million gift from the Family Larsson-Rosenquist Foundation has endowed an Oxford University research centre investigating the role of hormones in human milk production.
Dr. Aris Papageorghiou, co-founder of Intelligent Ultrasound, Principal Investigator and Global Health theme lead at the Nuffield Dept of Women\u2019s & Reproductive Health, is at the forefront of an exciting project that is transforming pregnancy care in Africa. The AI-based ScanNav FetalCheck ultrasound software, currently being tested in Uganda, promises to revolutionise prenatal care in low-resource settings by enabling scans without the need for specialists.
A groundbreaking study, recently published in JAMA Network Open, has uncovered the significant contributions of both childhood and adulthood cardiovascular risk factors to the development of cardiovascular disease (CVD) in middle age.\r\n\r\nThe research tracked 10,634 participants from the US, Finland, and Australia from childhood (1970s-1990s) until 2019. The mean age at childhood was 13.3 years, and the mean age for adulthood was 32.3 years.
A groundbreaking new study has shed light on how the landscape of heart disease has evolved in the UK over the past two decades. Researchers analyzed electronic health records from the Clinical Practice Research Datalink (CPRD GOLD and Aurum), encompassing a representative cohort of 22 million individuals. This included 1,650,052 people newly diagnosed with at least one cardiovascular disease (CVD) between 2000 and 2019, with an average age of 70.5 years, of whom 48% were women.
![\"\"](\"https://www.wrh.ox.ac.uk/news/pregnant-women-between-11-14-weeks-to-participate-in-this-groundbreaking-study/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n